辩证行为治疗与SSRI治疗边缘型人格障碍自杀行为的随机对照试验
该随机对照试验纳入84例边缘型人格障碍患者,比较6个月辩证行为治疗(DBT)与选择性5-羟色胺再摄取抑制剂联合临床管理(SSRI/M)对自杀相关事件(SRE)、自杀未遂及非自杀性自伤(NSSI)的疗效。结果显示DBT在减少SRE、自杀未遂和NSSI方面优于SSRI/M,但12个月随访时两组结局相当。
要点
- DBT在6个月治疗期内减少SRE和自杀未遂优于SSRI/M。
- DBT组NSSI计数显著低于SSRI/M组。
- 12个月随访时两组结局无显著差异。
核心结论
- 6个月DBT在减少边缘型人格障碍患者的SRE和NSSI行为方面比6个月SSRI/M更有效。
研究设计与样本
- 随机对照试验纳入84例边缘型人格障碍患者,过去6个月有超过1次自杀未遂、SRE或NSSI事件,且过去一年有另一次此类行为。
- 参与者随机接受DBT或SSRI/M治疗6个月,三分之二共病重性抑郁障碍。
主要发现
- 治疗6个月期间DBT组SRE显著少于SSRI/M组。
- DBT组自杀未遂显著少于SSRI/M组。
- 生存分析显示DBT组任何SRE风险显著低于SSRI/M组,但自杀未遂风险无差异。
- DBT组NSSI计数显著低于SSRI/M组。
- 两组抑郁严重程度和自杀意念下降程度相当;治疗6个月后SSRI/M组重性抑郁障碍率显著低于DBT组。
关键数值与推荐
- 12个月随访(治疗阶段完成后6个月)时两组结局相当。
临床怎么用
- 对于边缘型人格障碍伴反复自杀相关行为的患者,可优先考虑DBT以减少SRE和NSSI。
- SSRI/M可能更适合改善共病抑郁,但减少自杀行为效果不及DBT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors compared the efficacy of 6 months of dialectical behavior therapy (DBT) to 6 months of selective serotonin reuptake inhibitors with clinical management (SSRI/M) in reducing suicide-related events (SREs), suicide attempts, nonsuicidal self-injury (NSSI), and related clinical outcomes in individuals diagnosed with borderline personality disorder. METHODS: The study sample comprised 84 individuals with borderline personality disorder; more than one suicide attempt, SRE, or NSSI episode in the past 6 months; and another of these behaviors in the past year. Two-thirds had comorbid major depressive disorder. Participants were randomly assigned to receive DBT or SSRI/M. Poisson models were used to analyze numbers of suicide attempts and SREs, and a zero-inflated Poisson model was used for NSSI behaviors. Survival analysis was performed with the log-rank test for time to first suicide attempt or SRE. Follow-up assessments at 12 months were analyzed in a separate model. Mixed-effects regression was used to compare quantitative outcomes. RESULTS: Significantly fewer SREs occurred in the DBT arm compared with the SSRI/M arm during the 6-month treatment phase. Significantly fewer suicide attempts occurred in the DBT arm compared with the SSRI/M arm. Survival analysis indicated significantly lower risk for having any SRE in the DBT arm compared with the SSRI/M arm, but no difference in risk of suicide attempt. DBT participants had significantly lower NSSI counts than SSRI/M participants. Severity of depression and suicidal ideation decreased comparably in both treatment groups. After 6 months of treatment, the rate of major depressive disorder was significantly lower in the SSRI/M arm compared with the DBT arm. At 12-month follow-up (6 months after completion of the treatment phase), outcomes were comparable between the two groups. CONCLUSIONS: Six months of DBT showed greater efficacy than 6 months of SSRI/M in reducing SRE and NSSI behaviors in patients with borderline personality disorder.
引用
- Brodsky BS, Galfalvy H, Mann JJ, et al. Dialectical Behavior Therapy Versus Serotonin Reuptake Inhibitor Treatment for Suicidal Behavior in Borderline Personality Disorder: A Randomized Controlled Trial. Am J Psychiatry. 2025. PMID: 41190740. doi:10.1176/appi.ajp.20240298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。